CORC

在结果中检索

CORC

浏览/检索结果: 共526条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Graph-to-Graph: Towards Accurate and Interpretable Online Handwritten Mathematical Expression Recognition. 会议论文
线上会议, 2021-2-2至2021-2-9
作者:  Jin-Wen Wu;  Fei Yin;  Yan-Ming Zhang;  Xu-Yao Zhang;  Cheng-Lin Liu
收藏  |  浏览/下载：2/0  |  提交时间：2022/01/20
Real-Time Radiation Monitoring System with Interlock Protection Mechanism in Taiwan Photon Source 会议论文
Brazil, 2021
作者:  Y.C. Lin;  A.Y. Chen;  C.-R. Chen;  S.J. Huang;  S.P. Kao
收藏  |  浏览/下载：4/0  |  提交时间：2022/01/18
Use of a Noise IoT Detection System to Measure the Environmental Noise in Taiwan Light Source 会议论文
Brazil, 2021
作者:  P.J. Wen;  S.P. Kao;  S.Y. Lin;  Y.C. Lin
收藏  |  浏览/下载：2/0  |  提交时间：2022/01/18
GPO:Global Plane Optimization for Fast and Accurate Monocular SLAM Initialization 会议论文
法国巴黎线上会议, 2020.5.31-2020.8.31
作者:  Du SC(杜思聪);  Guo HK(郭亨凯);  Chen Y(陈尧);  Lin YL(林懿伦);  Meng XB(孟祥冰)
收藏  |  浏览/下载：17/0  |  提交时间：2021/06/15
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05
Classification of Schizophrenia Patients and Healthy Controls Using ICA of Complex-Valued fMRI Data and Convolutional Neural Networks 会议论文
16th International Symposium on Neural Networks, ISNN 2019, Moscow, Russia, 2019-07-10
作者:  Qiu, Yue;  Lin, Qiu-Hua;  Kuang, Li-Dan;  Zhao, Wen-Da;  Gong, Xiao-Feng
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace